INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Results

76,375 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
21
JD
John Angela DDirector
TTITETRA TECHNOLOGIES INC
Option exercise
M—
37.7K sh
Jun 12, 2026Jun 15, 2026
Page 818 of 1910
← PrevNext →
traded Jun 12, 2026
+3d
SEC Form 4

Evidence

21
PG
Park David GDirector
OKLOOklo Inc.
Grant or award
A—
3,213 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

21
KJ
Kaiser Joseph JohnDirector
MNTNMNTN, Inc.
Grant or award
A—
23.4K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

21
HA
Haddad David AlanDirector
TTDTrade Desk, Inc.
Grant or award
A—
11.8K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

21
FJ
Flinn JosephDirector
HUTHut 8 Corp.
Option exercise
M—
23.0K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

21
ME
Makov EfratDirector
CRNTCERAGON NETWORKS LTD
Open-market sale
SELL$15K
5,000 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

21
PT
Peters Mark TDirector
OKLOOklo Inc.
Grant or award
A—
3,213 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

21
FL
Feldmann Cynthia LDirector
UFPTUFP TECHNOLOGIES INC
Option exercise
M—
1,200 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

20
FL
Feldmann Cynthia LDirector
UFPTUFP TECHNOLOGIES INC
Option exercise
M$53K
1,200 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

20
HJ
Haas JasonDirector
LGNDLIGAND PHARMACEUTICALS INC
Option exercise
M$155K
3,000 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

19
VL
Villacrez Vicki LDirector, Executive Vice President & CFO
TDSTELEPHONE & DATA SYSTEMS INC /DE/
Option exercise
M$407K
10.2K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

19
BD
Bloom Paul DDirector, CEO
GEVOGevo, Inc.
Open-market sale · 10b5-1 plan
SELL$50K
35.2K sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

19
WS
Wallace SallyEVP, Chief Operating Officer
DRSLeonardo DRS, Inc.
Open-market sale · 10b5-1 plan
SELL$65K
1,300 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

18
AB
Albert BenjaminDirector, CEO
HCATHealth Catalyst, Inc.
Tax withholding
F$58K
34.5K sh
Jun 10, 2026Jun 15, 2026
traded Jun 10, 2026
+5dSEC Form 4

Evidence

17
RG
Ries GrantDirector
MNTNMNTN, Inc.
Grant or award
A—
23.4K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

17
ME
Makov EfratDirector
CRNTCERAGON NETWORKS LTD
Option exercise
M—
5,000 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

17
RA
Rosenberg AaronChief Financial Officer
ONCBeOne Medicines Ltd.
Grant or award
A—
71.2K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

17
OS
Oneal E StanleyDirector
HUTHut 8 Corp.
Option exercise
M—
15.5K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

17
EP
Ebrahimi PegahDirector
ENVXEnovix Corp
Grant or award
A—
29.1K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

17
OL
Orfanos LouDirector
THRYThryv Holdings, Inc.
Grant or award
A—
38.3K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

17
MO
Mahoney OwenDirector
HASHASBRO, INC.
Grant or award
A—
2,224 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

17
WS
Weingartner StefanDirector
SAROStandardAero, Inc.
Option exercise
M—
6,011 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

17
BH
Blumenthal Neil HarrisDirector
SGSweetgreen, Inc.
Grant or award
A—
24.1K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

17
BB
Battle Sean BernardDirector
BBAIBigBear.ai Holdings, Inc.
Grant or award
A—
36.1K sh
Jun 14, 2026Jun 15, 2026
traded Jun 14, 2026
+1dSEC Form 4

Evidence

17
MB
McGee Sharon D. BoothDirector
TTITETRA TECHNOLOGIES INC
Option exercise
M—
37.7K sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

17
AO
Arazi Doron OvadiaChief Executive Officer
CRNTCERAGON NETWORKS LTD
Grant or award
A—
66.7K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

17
MF
Miller Thomas F.Director
VCYTVERACYTE, INC.
Grant or award
A—
5,272 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

16
BT
Bowron Kimberly TChief of Staff
GEVOGevo, Inc.
Open-market sale · 10b5-1 plan
SELL$22K
15.5K sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

16
VL
Villacrez Vicki LDirector, Executive Vice President & CFO
TDSTELEPHONE & DATA SYSTEMS INC /DE/
Tax withholding
F$191K
4,780 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

16
GD
Gendenjamts DavaajargalVP Acctg and Treasurer
GEVOGevo, Inc.
Open-market sale · 10b5-1 plan
SELL$6,118
4,293 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

16
KM
Krupka Devin MController, PAO
BANDBandwidth Inc.
Open-market sale · 10b5-1 plan
SELL$30K
456 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

16
HJ
Haas JasonDirector
LGNDLIGAND PHARMACEUTICALS INC
Option exercise
M$52K
1,000 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

15
RD
Rigler DonPrincipal Accounting Officer
APPFAPPFOLIO INC
Open-market sale · 10b5-1 plan
SELL$24K
150 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

14
LE
Lentell EricChief Legal & Strategy Officer
ACHRArcher Aviation Inc.
Open-market sale
SELL$19K
3,754 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

14
GS
Glaser ShelaghCFO
SNPSSYNOPSYS INC
Open-market sale · 10b5-1 plan
SELL$1.53M
3,394 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

13
FE
Feder EricDirector
OPENOpendoor Technologies Inc.
Grant or award
A—
41.7K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

13
SA
Shafer AndrewChief Mktg Cust & Brnd Officer
GEVOGevo, Inc.
Open-market sale · 10b5-1 plan
SELL$13K
9,443 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

13
MA
Minson AmberEVP, Chief Marketing Officer
SNBRSleep Number Corp
Disposition to issuer
D$1,739
4,293 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

13
DM
Dugan MargaretDirector
ONCBeOne Medicines Ltd.
Grant or award
A—
19.0K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

13
BE
Barr EliavDirector
VCYTVERACYTE, INC.
Grant or award
A—
5,272 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence